GlaxoSmithKline is sending 340B covered entities refunds for overcharges totaling $100 or more for purchases of two dosage forms of [...] …
Category: Providers
While two drug manufacturers have recently relaxed or suspended their 340B contract pharmacy restrictions as a result of state laws [...] …
The lead plaintiff in the legal battle that resulted in Medicare proposing an unusual lump sum payback for hospitals’ lost [...] …
Congress should let for-profit hospitals into the 340B drug pricing program as “a long overdue evolutionary step” that will advance [...] …
Changes in the ways Medicare calculates hospitals’ shares of low-income patients that were finalized in a recent payment rule will [...] …
Hospitals charge, on average, 500% of their acquisition cost for 20 individual medicines that account for the largest share of [...] …
The creation of a claims clearinghouse and increasing both the funding and authority of the federal agency overseeing the 340B [...] …
A recently proposed list of planned Medicare payments for individual 340B hospitals is seen as ammunition to some 340B critics. [...] …
As the not-for-profit hospital sector slowly emerges from its worst financial year in recent history, some of those organizations’ bottom [...] …
The U.S. Senate Finance Committee yesterday voted 26-1 to pass a pharmacy benefit manager reform bill that would cut providers’ [...] …